PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
 
Antimicrob Agents Chemother. 2008 February; 52(2): 497–504.
Published online 2007 November 12. doi:  10.1128/AAC.01199-07
PMCID: PMC2224728

The P-113 Fragment of Histatin 5 Requires a Specific Peptide Sequence for Intracellular Translocation in Candida albicans, Which Is Independent of Cell Wall Binding[down-pointing small open triangle]

Abstract

The activity of histatin 5 (Hst 5) against Candida albicans is initiated through cell wall binding, followed by translocation and intracellular targeting. The C. albicans cell wall protein Ssa2 is involved in the transport of Hst 5 into cells as part of cell killing. P-113 (a 12-amino-acid candidacidal active fragment of Hst 5) and P-113Q2.10 (which is inactivated by a glutamine substitution of the Lys residues at positions 2 and 10) were compared for their levels of cell wall binding and intracellular translocation in Candida wild-type (wt) and ssa2Δ strains. Both P-113 and P-113Q2.10 bound to the walls of C. albicans wt and ssa2Δ cells, although the quantity of P-113Q2.10 in cell wall extracts was higher than that of P-113 in both strains. Increasing the extracellular NaCl concentration to 100 mM completely inhibited the cell wall association of both peptides, suggesting that these interactions are primarily ionic. The accumulation of P-113 in the cytosol of wt cells reached maximal levels within 15 min (0.26 μg/107 cells), while ssa2Δ mutant cells had maximal cytosolic levels of less than 0.2 μg/107 cells even after 30 min of incubation. Furthermore, P-113 but not P-113Q2.10 showed specific binding with a peptide array of C. albicans Ssa2p. P-113Q2.10 was not transported into the cytosol of either C. albicans wt or ssa2Δ cells, despite the high levels of cell wall binding, showing that the two cationic lysine residues at positions 2 and 10 in the P-113 peptide are important for transport into the cytosol and that binding and transport are independent functional events.

Candida albicans is an opportunistic pathogen that causes oropharyngeal candidiasis in compromised hosts (9). Oral mucosal infections by Candida species are also frequent in patients receiving radiation therapy for head and neck cancer (25, 26, 30) or in individuals with compromised salivary function (15, 19). There are three main classes of clinically useful antifungal agents: polyene antibiotics, the fluoropyrimidine flucytosine, and azoles (36). However, the toxicities of the currently used polyene antifungal drugs and the emergence of candidal species resistant to fluoropyrimidine flucytosine and azole-based agents have resulted in the initiation of a search for innate peptide antibiotics as alternative drug therapies (32).

Histatins are a group of small, histidine-rich cationic antimicrobial peptides secreted into the saliva by human parotid and submandibular-sublingual glands (1). These proteins exhibit fungicidal activity against several Candida species, Saccharomyces cerevisiae, and Cryptococcus neoformans (11, 20). Among at least 50 histatin peptides derived from posttranslational proteolytic processing (7, 18), histatin 5 (Hst 5), which contains 24 amino acids, has the highest level of activity against C. albicans (38).

The fungicidal activity of Hst 5 is a distinctive multistep mechanism involved in the binding of Hst 5 to Candida cell wall proteins, followed by translocation to intracellular compartments (24). When it reaches the cytotosol, Hst 5 causes the nonlytic efflux of cellular ATP and the loss of other small nucleotides and ions from the cell through mechanisms that involve the Trk1p potassium transporter (3, 4). The initial binding of histatins to the candidal cell wall is followed by rapid internalization, which can be slowed by low temperature conditions or azide pretreatment, which depletes the cell of energy (17, 39). Thus, specific energy-dependent processes are involved in the binding and/or uptake of the peptide. Hst 5 was shown to have weak interactions with liposome membranes compared with those of the histatin variant dhvar4 (8), implying that translocation across biological membranes requires additional proteins. In this regard, we identified the C. albicans Ssa2 protein to be a binding partner for Hst 5 (23), and ssa2Δ mutants are defective in Hst 5 translocation and killing (24). Ssa proteins are conserved members of the heat shock protein 70 family in yeast, of which Candida only has two members: Ssa1p and Ssa2p. The major localization of Ssa proteins in Candida is the cytoplasm, where they are involved in heat shock protection and assistance in protein folding and translocation across the membranes. The C. albicans Ssa1 and Ssa2 proteins are both exported to the cell wall, where the Ssa2 protein but not the Ssa1p protein is required for Hst 5 binding and intracellular uptake.

On the basis of the structure of Hst 5, several synthetic congeners have been designed and evaluated for their activities against a variety of antibiotic-resistant bacteria and fungi (16, 27). One histatin variant with a higher amphipathicity (dhvar4) was found to have enhanced non-energy-dependent fungicidal activity (28), while cyclized histatin 3 was 100-fold more active against Saccharomyces cerevisiae than Hst 5 (6). Both of these structural derivatives appear to have more disruptive interactions with fungal membranes than the parent Hst 5 protein (6, 28). To evaluate whether histidine residues are crucial for the activity of Hst 5, amino acid substitutions were made in two adjacent histidine residues without altering the conformation of the protein, and these substitutions resulted in 8- to 20-fold reductions in candidacidal activity (33). Among other derivatives, P-113 (amino acid residues 4 to 16 of Hst 5) is as active as full-length Hst 5 in terms of its in vitro candidacidal activity (27). However, the replacement of the Lys residue at position 2 (Lys2) and Lys10 of P-113 with glutamine (P-113Q2.10) resulted in the nearly complete loss of killing function, while the substitution of histidine residues within this peptide did not alter the killing function (27). Interestingly, the replacement of four cationic residues (Lys2 Arg3, Arg9, Lys10) of P-113 with glutamine resulted in the complete loss of candidacidal activity; however, increasing the amphipathicity of P-113 by amino acid substitution had no effect on its killing activity (27). Thus, that study identified a minimum of two nonhistidine cationic residues that are crucial for the toxicity of the peptide and further showed that the degree of the amphipathic molecular moment of the peptide is unrelated to its killing activity.

While the overall process of binding and uptake required for the antifungal activity of Hst 5 has been well studied, the individual cellular components involved in translocation into the cell remain largely unknown. Therefore, P-113 and the inactive substituted peptide P-113Q2.10 were chosen to probe for the competence of the intracellular translocation in a C. albicans wild-type (wt) strain and an ssa2Δ mutant strain. We examined translocation by measuring the time-dependent levels of each peptide in the cell wall and cytosolic compartments and found that P-113Q2.10 is competent in cell wall binding but is defective in cytosolic translocation. Thus, we show for the first time that the cell wall binding and intracellular transport of Hst 5 in C. albicans are independent events and that translocation is dependent on the primary sequence of the imported peptide.

MATERIALS AND METHODS

Materials.

C. albicans wt strain CAF4-2 is the parental strain for the ssa1Δ and ssa2Δ mutant strains used in these experiments. Cells were cultured for assays in yeast nitrogen base (YNB; Qbiogene, Morgan Irvine, CA), maintained on yeast extract-peptone-dextrose (Qbiogene) agar plates, and recultured monthly from −78°C stocks. The peptides (P-113 and P-113Q2.10) and N-terminal biotin-labeled peptides were synthesized by using standard solid-phase synthesis protocols and were purified by reversed-phase high-performance liquid chromatography by Genemed Synthesis Inc. (San Francisco, CA). The primary structures of these peptides are shown in Table Table11.

TABLE 1.
Primary structures of antimicrobial peptides used in this study

Candidacidal assay.

The activities of the peptides against the Candida strains were tested by using standard microdilution plate candidacidal assays (37) and radial diffusion assays (21). For the candidacidal assays, C. albicans cells were grown in YNB medium and washed twice with 10 mM sodium phosphate buffer (NaPB; Na2HPO4, NaH2PO4, pH 7.4), and then the cells (1 × 106) were mixed with different concentrations of the peptides and incubated at room temperature with constant shaking for 1 h. The cell suspensions were diluted in 10 mM NaPB, and aliquots of 500 cells were spread onto YNB agar plates and incubated for 48 h at room temperature to visualize the surviving colonies. Cell survival was expressed as a percentage of that for the control, and the loss of viability was calculated as [1 − (number of colonies from peptide-treated cells/number of colonies from control cells)] × 100. Candidacidal assays were performed in triplicate. For the radial diffusion assay, C. albicans cells were grown in YNB medium overnight and washed twice with 10 mM NaPB. Washed yeast-phase C. albicans cells (1 × 106 CFU) were trapped in thin underlay gels, which contained 9 mM sodium phosphate, 1 mM sodium citrate buffer, 1% (wt/vol) agarose (A 6013; Sigma), and 0.3 mg of Sabouraud dextrose broth (Difco)/ml. In some experiments, the underlay agars were supplemented with 99 mM sodium phosphate. Stock peptide solutions and serial twofold dilutions with concentrations ranging from 7.81 μM to 250 μM were prepared in distilled water. Peptide samples (5 μl) were loaded into 3-mm-diameter wells that had been punched in the underlay gels. After incubation at 37°C for 3 h, a 10-ml overlay gel of 1% agarose and 6% Sabouraud dextrose broth was poured on the underlay gel. After the plates were incubated overnight at 37°C, the clear-zone diameters were measured to the nearest 0.1 mm and graphed against the peptide concentration. Zone diameters are expressed in units (0.1 mm = 1 unit).

Interaction of P-113 with the component of the Candida cell wall and cytoplasmic transport of P-113.

The localization of the peptides in the C. albicans wt and ssa2Δ mutant strains was examined by two sequential cellular fractionation steps consisting of β-mercaptoethanol (β-ME) cell wall extraction, followed by cytosolic fractionation, as described previously (24). Briefly, early-log-phase cells (1 × 108) were washed twice with 10 mM NaPB and suspended in 1 ml of NaPB, and biotin-labeled peptides were added to a final concentration of 31.25 μM. The cell mixtures were incubated with constant shaking for 0, 5, 15, 30, 60, and 90 min. After centrifugation at 6,000 rpm and 4°C, the supernatant of each sample was collected in a fresh 1.5-ml tube to measure the level of remaining peptides, and the cells were washed with 10 mM NaPB. β-ME-extractable cell wall components were released by incubation of the cell suspension in ammonium carbonate buffer (pH 8.0) containing 1% (vol/vol) β-ME for 30 min at 37°C. The supernatant containing the cell wall extract obtained by extraction with β-ME was collected following centrifugation at 500 × g. The β-ME-treated cells were then washed twice with 10 mM NaPB, and the cell pellet was disrupted in 1 volume of 0.5-mm glass beads and 1 volume of cold lysis buffer supplemented with protease inhibitors (10 mM NaPB, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 1 μg/ml aprotinin, 1 μg/ml pepstatin A, 1 μg/ml leupeptin, and 1 μg/ml benzamidine). Cell lysates were prepared by using a Fastprep apparatus at 4°C. The cytosolic fraction was collected following centrifugation at 13,000 rpm for 10 min. The protein concentrations of the cell wall extracts obtained by extraction with β-ME and the cytosolic proteins were measured by a bicinchoninic acid assay. Subsequently, the cell wall proteins and cytosolic proteins were electrophoresed by 16% Tricine sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) (29) and transferred to polyvinylidene difluoride (PVDF) membranes. Supernatant samples were loaded onto PVDF membranes by using a slot blot apparatus (Hoefer) that had been equilibrated in Tris-buffered saline (TBS; 20 mM Tris, 500 mM NaCl, pH 7.5) for 10 min. The membrane was then incubated for 60 min in blocking solution (3% skim milk in TBS containing 0.05% Tween 20 [TBST]). After a brief wash in TBST, the membrane was incubated for 1 h in blocking solution containing 1,000-fold-diluted streptavidin conjugated with horseradish peroxidase (HRP; Pierce). Finally, the membrane was washed twice in TBST and once in TBS and was finally submerged in HRP color development solution (50 ml of TBS containing 30 μl of H2O2 mixed with 0.3% of chloronaphthol in 10 ml of ice-cold methanol). The concentrations of P-113 and P-113Q2.10 in the cell wall extracts and the cytosolic extracts (10 μg/lane) were determined by comparison with P-113 and P-113Q2.10 concentration standards (0.5, 0.25, 0.125, and 0.06125 μg) and analysis with Quantity One software (version 4.2).

Mapping of P-113 and P-113Q2 binding motifs on Ssa2 peptide arrays.

The primary sequence of C. albicans Ssa2p was obtained from the Universal Protein Resource (http://www.ebi.uniprot.org/index.shtml), and a peptide array of the Ssa2 protein was designed so that the peptide fragment consisted of sequential 13-amino-acid fragments with an overlap of 2 amino acids between each peptide. Overlapping peptides comprising the entire sequence of Ssa2p (645 amino acids) were synthesized by JPT Peptide Technologies GmbH (Berlin, Germany) and were printed on cellulose-β-alanine membranes. The preparation of the membrane, as well as control experiments for the detection of the false-positive binding of streptavidin-HRP to the membrane, was performed by following the manufacturer's protocol. Spot array cellulose-β-alanine membranes were rinsed with methanol for 5 min, followed by three washes with 20 ml TBS (50 mM Tris-HCl, 137 mM NaCl, 2.7 mM KCl, pH 8.0) for 10 min each. The membrane was then blocked with Starting Block (Pierce) blocking buffer (an albumin and endogenous biotin-free buffer compatible with a streptavidin system) for 2 h at room temperature. P-113 or P-113Q2.10 (2 μM) was added to the blocking buffer, and the mixture was incubated with the membrane for 3 h at room temperature. After an extensive wash with TBS buffer to remove the unbound peptides, the membrane was incubated with streptavidin-HRP (1:20,000) for 1 h at room temperature. After the membranes were washed six times with TBS buffer, they were developed with the SuperSignal West Pico chemiluminescent substrate (150 μl/cm2; Pierce) for 5 min and scanned by using a Fuji LAS-1000 Plus chemiluminescence imager. The repeatabilities of the binding signals were confirmed by reprobing each membrane following regeneration with regeneration buffer (62.5 mM Tris-HCl, 2% SDS, 0.7% 2-mercaptoethanol, pH 6.7) for 30 min at 50°C.

RESULTS

Candidacidal activities.

We have found that Hst 5 binds to Candida albicans cell wall Ssa proteins and is involved in the transport of Hst 5 into cells as part of its mechanism of cell killing (23), as evidenced by the results for Candida ssa2Δ mutants, which have a reduced uptake of Hst 5 and a subsequently reduced toxicity compared with the levels of uptake and toxicity for wt cells (24). It is not known if P-113 (the smaller active fragment of Hst 5) also utilizes this mechanism of binding and uptake. Therefore, the antifungal activities of P-113 and P-113Q2.10 were examined by using C. albicans ssa1Δ and ssa2Δ mutant strains by two independent assays: our standard candidacidal assay, in which cells are exposed to peptides for 1 h and then removed and placed in growth medium, and a radial diffusion assay, in which growing cells are continuously exposed to the peptide. These assays were compared, since the levels of expression of Ssa proteins may differ depending on the growth conditions. The treatment of C. albicans wt or ssa1Δ cells with P-113 (31.5 μM) under standard assay conditions (Fig. 1 A) resulted in 90% cell killing, while the ssa2Δ strain had reduced susceptibility (76% killing). At lower P-113 concentrations, both the ssa1Δ and the ssa2Δ strains had reduced sensitivities. In contrast, P-113Q2.10 (in which the Lys2 and Lys10 of P-113 are replaced with glutamine) had no activity against any of the Candida strains at concentrations below 31.5 μM and less than 10% killing at 31.5 μM (Fig. (Fig.1A).1A). When the activities of P-113 and P-113Q2.10 against the C. albicans wt and the ssa1 and ssa2Δ mutant strains were visualized by radial diffusion assays, they were found to be nearly identical to those obtained by conventional candidacidal assays (Fig. (Fig.1B).1B). P-113 had potent activity against the C. albicans wt and ssa1Δ strains, while the ssa2Δ strain had substantial resistance to this peptide (Fig. (Fig.1B,1B, left). P-113Q2.10 had very little activity against any of Candida strains (Fig. (Fig.1B,1B, right). Thus, P-113 has similar effects when its activities were measured by either conventional candidacidal assays or the radial diffusion assay; and as for Hst 5, Ssa2p is involved in the toxicity of P-113, while Ssa1p makes little contribution to the toxicity.

FIG. 1.
Candidacidal activities of P-113 and P-113Q2.10. The susceptibilities of cells to P-113 and P-113Q2.10 killing was examined with cells of the C. albicans wt (closed circles and open circles, respectively), ssa1Δ mutant (closed squares and open ...

Extracellular salt prevents cell wall binding and toxicity of P-113.

Because divalent cations and NaCl reduce the activity of P-113 (27), we questioned whether salts inhibit the initial interactions between P-113 and the cell wall or if subsequent translocation and/or cytosolic functions are affected. Since 100 mM NaPB completely inhibits the candidacidal activity of Hst 5 (22), we examined the effect of this salt concentration on the activities of P-113 and P-113Q2.10 by the radial diffusion assay. P-113 had potent activity against C. albicans cells in 10 mM NaPB (Fig. (Fig.2,2, left), but it was completely inactivated in the presence of 100 mM NaPB (Fig. (Fig.2,2, right). The low level of toxicity elicited by P-113Q2.10 at high concentrations (>62 μM) was also lost when it was incubated with 100 mM NaPB. Previous studies with Hst 3 have suggested that high external salt conditions prevent the efficient import of the protein into the cytosolic compartment, resulting in impaired toxicity (39). Therefore, we examined the cytosolic levels of translocated P-113 in C. albicans over a time course (5, 15, and 30 min) under conditions with low (10 mM NaPB) or high (100 mM NaPB) salt concentrations (Fig. (Fig.3).3). Total cytosolic proteins were extracted after incubation with biotin-labeled P-113 under each condition, and equal amounts of total protein were immunoblotted to detect the levels of P-113 (Fig. (Fig.3A,3A, middle panel). Under the conditions of the low salt concentration used for the candidacidal assays, P-113 was present in the C. albicans cytosol within 5 min, while P-113 was absent in cytosolic extracts from cells incubated under conditions with a high salt concentration (Fig. (Fig.3A,3A, middle panel). This result could be due to the loss of the transport function of bound P-113 or the inability of P-113 to bind to the cell wall under conditions with a high salt concentration. To differentiate between these two possibilities, cell wall proteins were stripped from whole C. albicans cells immediately following 5, 15, and 30 min of incubation of the cells with P-113 under conditions with low and high salt concentrations and immunoblotted as described above for the cytosolic extracts. P-113 was detected in the cell wall extracts within 5 min in cells suspended in 10 mM NaPB (Fig. (Fig.3B,3B, middle panel), but little to no P-113 was found in the cell walls of C. albicans cells incubated in 100 mM NaPB (Fig. (Fig.3B,3B, middle panel). These results show that the high-salt-concentration condition inhibits the initial binding of P-113 with the cell wall, so that subsequent cytosolic transport does not occur. Furthermore, the interruption of binding of P-113 to the cell wall by salt suggests that initial contacts between this protein and C. albicans cells are largely nonspecific ionic interactions that are disrupted under conditions with high salt concentrations.

FIG. 2.
Increasing salinity inhibits candidacidal activities of P-113 and P-113Q2.10. C. albicans wt cells were tested for their susceptibilities to P-113 and P-113Q2.10 in the presence or the absence of 100 mM NaPB by the radial diffusion assay. The antifungal ...
FIG. 3.
Conditions with high salt concentrations prevent the cell wall binding of P-113. CAF4-2 wt cells were incubated with biotin-labeled P-113 (31.5 μM) in 10 mM NaPB (closed circles) or 100 mM NaPB (closed diamonds) buffer for 1 to 30 min at 37°C. ...

P-113 but not P-113Q2.10 binds to a peptide array of Candida Ssa2p.

Since Hst 5 binds to Ssa2p as part of the mechanism of peptide uptake into the cell (24), we wanted to determine whether P-113 was also capable of direct interactions with Ssa2p. For this purpose, a peptide array of Ssa2p comprising the entire 645-amino-acid sequence was constructed so that each peptide spot consisted of sequential 13-amino-acid fragments from Ssa2p with an overlap of 2 amino acids between each peptide. Biotin-labeled P-113 or P-113Q2.10 was incubated with each membrane and extensively washed to remove unbound peptide, and bound P-113 or P-113Q2.10 was visualized by chemiluminescence. Strong binding of P-113 was detected in two regions of Ssa2p, spot 7 (AKRLIGRKFDDHE) and spot 23 (KRKNKKDISTNQR), while weaker binding was visualized with three other peptide fragments (Fig. (Fig.4,4, upper membrane). In sharp contrast, no binding with any region of Ssa2p was detected when P-113Q2.10 was used as a probe (Fig. (Fig.4,4, bottom membrane). These results show that P-113 is capable of direct binding to selective peptide regions of Ssa2p; however, the mutation of two amino acids in P-113Q2.10 results in the loss of this binding capability. This suggests that the reduced sensitivity of the ssa2Δ mutant to P-113 and the complete loss of antifungal activity of P-113Q2.10 could be a result of differences in the abilities of the peptides to bind with the Ssa2 protein and subsequent intracellular transport. Therefore, we next investigated the properties of the transport of P-113 or P-113Q2.10 into the cytosol in wt and ssa2Δ mutant cells.

FIG. 4.
P-113 binds to selective peptides in an Ssa2 peptide array, while P-113Q2.10 does not bind to the Ssa2 peptide array. Peptide arrays containing the complete library of the Candida albicans Ssa2 protein (JPT Peptide Technologies GmbH) were used to probe ...

P-113 import is facilitated, but not limited, by Ssa2p.

Cells were treated with 31.5 μM each peptide under low-salt-concentration conditions, as described above for the candidacidal assays, and three compartments (unbound peptide in the supernatant, cell wall-associated peptide, and cytosolic peptide) were collected for each cell type at selected time points. Biotin-labeled P-113 or P-113Q2.10 was added to C. albicans wt and ssa2Δ mutant cells; and then the unassociated peptide not taken up by the cells was collected from the supernatant over 5, 15, 30, 60, and 90 min and measured by slot blot analysis (Fig. (Fig.5).5). P-113 rapidly disappeared from the supernatant samples of wt cells, so that by 15 min no further free peptide was detected in the cell supernatants. The level of P-113 was also reduced in the ssa2Δ supernatant samples, but the time required for P-113 to be substantially depleted from the supernatant was increased to 30 min. Even after 90 min of incubation with ssa2Δ cells, some P-113 could be detected in the cell supernatant. In contrast, the levels of P-113Q2.10 were slightly reduced in the supernatants of both the C. albicans wt and ssa2Δ strains after 15 min of incubation, but they were not further reduced even after 90 min of incubation (Fig. (Fig.5).5). Thus, the cells took up P-113Q2.10 to a threshold level beyond which no further peptide could be adsorbed. This threshold level appeared to be equivalent in wt and ssa2Δ cells, suggesting that Ssa2p is not involved in the uptake of P-113Q2.10. In contrast, C. albicans ssa2Δ cells had a reduced velocity of uptake of P-113 as well as incomplete total uptake from the supernatant, showing the involvement of Ssa2p in the uptake of P-113, perhaps as a facilitator protein.

FIG. 5.
P-113 is rapidly depleted from cell supernatants following incubation with C. albicans wt and ssa2Δ cells, while P-113Q2.10 remains in the cell supernatant. C. albicans wt and ssa2Δ mutant cells were each incubated with biotin-labeled ...

P-113Q2.10 binds to the Candida cell wall but is defective in translocation.

To differentiate between cell wall binding and the intracellular transport of P-113 and P-113Q2.10, cell wall proteins were first extracted by β-ME, and then the cells were disrupted and the cytosol was collected. The protein content was normalized for each cell extract, and the content of P-113 or P-113Q2.10 at each time point was analyzed by immunoblotting. P-113 was detected in cell wall extracts of both wt and ssa2Δ strains within 5 min after addition of the peptide (Fig. 6 A). The P-113 levels in the cell wall reached a maximum by 15 min and then remained relatively constant over 90 min of treatment (Fig. (Fig.6C).6C). Cell wall extracts from both the wt and the ssa2Δ strains contained similar levels of P-113 (0.1 μg/107 cells). Surprisingly, cell wall extracts from both the wt and the ssa2Δ strains had significantly higher levels of P-113Q2.10 within 5 min of incubation (0.15 μg/107 cells) compared to the levels of P-113, and within 15 min the maximal level of P-113Q2.10 was nearly double (0.2 μg/107 cells) that of P-113 (Fig. 6B and C). As for P-113, no difference in the quantity of P-113Q2.10 in the cell wall extracts was observed between the wt and the ssa2Δ mutant. These results suggest that Ssa2p has no influence on the total level of P-113 or P-113Q2.10 in the cell wall but that its effect may be in the subsequent transport. In addition, the higher levels of P-113Q2.10 in the cell wall may reflect the fact that the peptide is accumulated within the wall but is unable to be transported intracellularly. Therefore, we next examined the cytosolic levels of P-113 and P-113Q2.10.

FIG. 6.
The cell wall association of P-113Q2.10 is greater than that of P-113 in both wt and ssa2Δ cells. Strain CAF4-2 wt and ssa2Δ cells were incubated with 31.5 μM biotin-labeled P-113 or P-113Q2.10 in 10 mM NaPB for 5 to 90 min at ...

Cytosolic P-113 was detected in the wt strain within 5 min of incubation and reached maximal levels within 15 min (0.26 μg/107 cells) (Fig. 7A and C). Subsequently, the cytosolic levels of P-113 were reduced in a linear manner to about 0.2 μg/107 cells after 90 min. In contrast, in the ssa2Δ mutant P-113 did not reach a maximal cytosolic concentration until 30 min of incubation with the peptide, and this level was less than 0.2 μg/107 cells. Thus, the ssa2Δ mutant had a reduced rate of cytosolic transport and reached a maximal cytosolic level that was slightly less than the level of P-113 peptide found in wt cells after 90 min. Strikingly, no amount of P-113Q2.10 peptide was detected in the cytosol of either C. albicans wt or ssa2Δ mutant cells (Fig. 7B and C). Preincubation of C. albicans wt cells with P-113Q2.10 inhibited the subsequent binding and uptake of P-113 (data not shown), showing that both peptides utilize the same binding sites on the cell wall. However, the mutation of two lysine residues of P-113, which created P-113Q2.10, resulted in the complete loss of intracellular transport of P-113Q2.10, although it is efficiently bound to the cell wall. Thus, the higher cell wall levels of P-113Q2.10 compared to those of P-113 likely reflect the inability of the peptide to be transported into the cell and the lack of turnover of peptide as a result of intracellular transport. Furthermore, Ssa2p appears to be involved in the efficiency of transport of P-113 into the cytosol.

FIG. 7.
P-113, but not P-113Q2.10, undergoes Ssa2p-dependent cytosolic translocation. C. albicans cells (wt or ssa2Δ) were incubated with 32 μM P-113 and P-113Q2.10 for 5 to 90 min in 10 mM NaPB at 37°C, and then the cells were fractionated ...

DISCUSSION

Peptide import into cells has attracted increased attention not only as a basis for understanding the basic mechanisms of intracellular trafficking of peptides but also for the generation of peptide-mediated drug delivery systems or targeted antimicrobial peptides (12). Because of the positive charge of cationic antifungal peptides at physiological pH, the prevailing view is that the initial binding to the cell surface is through electrostatic interactions with anionic surface mannans and glycans. Indeed, we found this to be the case, as an increase in the extracellular salt concentration to 100 mM completely inhibited the binding of P-113 as well as that of P-113Q2.10, showing that initial binding with the cell wall is predominantly through electrostatic interactions rather than by binding with specific amino acid sequences or motifs. However, the charge interactions between cationic antimicrobial peptides and the anionic moieties of cell surfaces can be important determinants for organism specificity as well as salt sensitivity (31). Cationic charge clustering of dibasic amino acids such as Arg or Lys is commonly found at the N termini of many open-chain antimicrobial peptides. Thus, the number, proximity, and topology of charged amino acids may confer the specificity of binding interactions with cell surface molecules. For Candida, outer cell wall galactomannans, mannans, or beta-1,3-glucans may possess specific determinants of binding for Hst 5. Such interactions are supported by the findings from our previous studies, which found reduced killing by Hst 5 upon digestion of the Candida cell wall, producing spheroplasts (13), and reduction of the total level of cell-associated Hst 5 upon incubation in higher-ionic-strength buffers (10).

P-113 binding with the cell wall is transitory, since the peptide is detected in the cytosol within 5 min. Furthermore, the lower levels of P-113 associated with the cell wall compared with those of the translocation-incompetent peptide P-113Q2.10 indicate that the association of the peptide with the cell wall is a transitional step prior to internalization. Thus, ongoing functional import reduces the cell wall levels of the peptide as the peptide is cycled into the cell cytosol, while translocation-incompetent peptides remain bound at saturated levels with the cell wall. The mechanism by which candidal cells rapidly import Hst 5 peptides is yet unknown; however, this work has shown that import is dependent upon a specific amino acid sequence found in P-113 but not in P-113Q2.10 and that additional candidal proteins, including Ssa2p, also facilitate import. One possibility is that the Ssa2 protein serves as a chaperone that transfers cell wall-bound peptides to a membrane permease which specifically transports cationic peptides. S. cerevisiae uses at least four plasma membrane permeases, DUR3 and SAM3 (34), AGP2 (2), and GAP1 (35), that catalyze the uptake of extracellular polyamines in an energy-dependent manner. Candidal homologues of these permeases are potential candidates as intracellular transporters of Hst 5. We are investigating this possibility by evaluation of the translocation of Hst 5 in C. albicans permease null mutants. Alternatively, Hst 5 could be taken up by Ssa2-mediated endocytosis and then released into the cytosol by retrograde transport, as has been described for yeast killer toxins in S. cerevisiae (5, 14). Evidence for the involvement of endocytotic processes has also been reported for branched Hst 5 analogues (40). However, the time required for endocytotic trafficking does not seem to coincide with the rapid (<5 min) appearance of Hst 5 in the cytosol, nor does Hst 5 possess a classical HDEL endoplasmic retention signal essential for retrograde transport in S. cerevisiae. However, endocytotic processes in Candida are not well understood, leaving this possibility open to further study.

This work shows that intracellular transport is the specific and rate-limiting step for the delivery of cationic peptides to the cytosol of C. albicans. Similarities in the hydrophobic molecular moments and net charges between P-113 and P-113Q2.10 (27) suggest that the transport process depends on the recognition of specific amino acid sequences or motifs of the transported substrate rather than helical structural features. It will be important to identify the substrate requirements for intracellular transport as well as the translocation mechanism in order to best design peptides for therapeutic use for candidiasis.

Acknowledgments

This work was supported by U.S. PHS R01 grant DE010641 from the National Institute of Dental and Craniofacial Research (to M.E.) and a Korea Research Foundation grant funded by the Korean Government (MOEHRD) (KRF-2006-352-C00061) (to W.S.J.).

Footnotes

[down-pointing small open triangle]Published ahead of print on 12 November 2007.

REFERENCES

1. Ahmad, M., M. Piludu, F. G. Oppenheim, E. J. Helmerhorst, and A. R. Hand. 2004. Immunocytochemical localization of histatins in human salivary glands. J. Histochem. Cytochem. 52:361-370. [PubMed]
2. Aouida, M., A. Leduc, R. Poulin, and D. Ramotar. 2005. AGP2 encodes the major permease for high affinity polyamine import in Saccharomyces cerevisiae. J. Biol. Chem. 280:24267-24276. [PubMed]
3. Baev, D., X. S. Li, J. Dong, P. Keng, and M. Edgerton. 2002. Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans. Infect. Immun. 70:4777-4784. [PMC free article] [PubMed]
4. Baev, D., A. Rivetta, S. Vylkova, J. N. Sun, G. F. Zeng, C. L. Slayman, and M. Edgerton. 2004. The TRK1 potassium transporter is the critical effector for killing of Candida albicans by the cationic protein, histatin 5. J. Biol. Chem. 279:55060-55072. [PubMed]
5. Breinig, F., T. Sendzik, K. Eisfeld, and M. J. Schmitt. 2006. Dissecting toxin immunity in virus-infected killer yeast uncovers an intrinsic strategy of self-protection. Proc. Natl. Acad. Sci. USA 103:3810-3815. [PubMed]
6. Brewer, D., and G. Lajoie. 2002. Structure-based design of potent histatin analogues. Biochemistry 41:5526-5536. [PubMed]
7. Castagnola, M., R. Inzitari, D. V. Rossetti, C. Olmi, T. Cabras, V. Piras, P. Nicolussi, M. T. Sanna, M. Pellegrini, B. Giardina, and I. Messana. 2004. A cascade of 24 histatins (histatin 3 fragments) in human saliva. Suggestions for a pre-secretory sequential cleavage pathway. J. Biol. Chem. 279:41436-41443. [PubMed]
8. Den Hertog, A. L., H. W. Wong Fong Sang, R. Kraayenhof, J. G. Bolscher, W. Van't Hof, E. C. Veerman, and A. V. Nieuw Amerongen. 2004. Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization. Biochem. J. 379:665-672. [PubMed]
9. de Repentigny, L., D. Lewandowski, and P. Jolicoeur. 2004. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin. Microbiol. Rev. 17:729-759. [PMC free article] [PubMed]
10. Dong, J., S. Vylkova, X. S. Li, and M. Edgerton. 2003. Calcium blocks fungicidal activity of human salivary histatin 5 through disruption of binding with Candida albicans. J. Dent. Res. 82:748-752. [PubMed]
11. Driscoll, J., C. Duan, Y. Zuo, T. Xu, R. Troxler, and F. G. Oppenheim. 1996. Candidacidal activity of human salivary histatin recombinant variants produced by site-directed mutagenesis. Gene 177:29-34. [PubMed]
12. Eckert, R., J. He, D. K. Yarbrough, F. Qi, M. H. Anderson, and W. Shi. 2006. Targeted killing of Streptococcus mutans by a pheromone-guided “smart” antimicrobial peptide. Antimicrob. Agents Chemother. 50:3651-3657. [PMC free article] [PubMed]
13. Edgerton, M., S. E. Koshlukova, T. E. Lo, B. G. Chrzan, R. M. Straubinger, and P. A. Raj. 1998. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J. Biol. Chem. 273:20438-20447. [PubMed]
14. Eisfeld, K., F. Riffer, J. Mentges, and M. J. Schmitt. 2000. Endocytotic uptake and retrograde transport of a virally encoded killer toxin in yeast. Mol. Microbiol. 37:926-940. [PubMed]
15. Fotos, P. G., and J. W. Hellstein. 1992. Candida and candidosis. Epidemiology, diagnosis and therapeutic management. Dent. Clin. N. Am. 36:857-878. [PubMed]
16. Giacometti, A., O. Cirioni, W. Kamysz, G. D'Amato, C. Silvestri, M. S. Del Prete, A. Licci, A. Riva, J. Lukasiak, and G. Scalise. 2005. In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. Antimicrob. Agents Chemother. 49:1249-1252. [PMC free article] [PubMed]
17. Gyurko, C., U. Lendenmann, R. F. Troxler, and F. G. Oppenheim. 2000. Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. Antimicrob. Agents Chemother. 44:348-354. [PMC free article] [PubMed]
18. Hardt, M., L. R. Thomas, S. E. Dixon, G. Newport, N. Agabian, A. Prakobphol, S. C. Hall, H. E. Witkowska, and S. J. Fisher. 2005. Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry. Biochemistry 44:2885-2899. [PubMed]
19. Haveman, C. W., and S. W. Redding. 1998. Dental management and treatment of xerostomic patients. Tex. Dent. J. 115:43-56. [PubMed]
20. Helmerhorst, E. J., I. M. Reijnders, W. van't Hof, I. Simoons-Smit, E. C. Veerman, and A. V. Amerongen. 1999. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob. Agents Chemother. 43:702-704. [PMC free article] [PubMed]
21. Jang, W. S., H. K. Kim, K. Y. Lee, S. A. Kim, Y. S. Han, and I. H. Lee. 2006. Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium. FEBS Lett. 580:1490-1496. [PubMed]
22. Koshlukova, S. E., T. L. Lloyd, M. W. Araujo, and M. Edgerton. 1999. Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J. Biol. Chem. 274:18872-18879. [PubMed]
23. Li, X. S., M. S. Reddy, D. Baev, and M. Edgerton. 2003. Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J. Biol. Chem. 278:28553-28561. [PubMed]
24. Li, X. S., J. N. Sun, K. Okamoto-Shibayama, and M. Edgerton. 2006. Candida albicans cell wall Ssa proteins bind and facilitate import of salivary histatin 5 required for toxicity. J. Biol. Chem. 281:22453-22463. [PubMed]
25. Ramirez-Amador, V., S. Silverman, Jr., P. Mayer, M. Tyler, and J. Quivey. 1997. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 84:149-153. [PubMed]
26. Redding, S. W., R. C. Zellars, W. R. Kirkpatrick, R. K. McAtee, M. A. Caceres, A. W. Fothergill, J. L. Lopez-Ribot, C. W. Bailey, M. G. Rinaldi, and T. F. Patterson. 1999. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J. Clin. Microbiol. 37:3896-3900. [PMC free article] [PubMed]
27. Rothstein, D. M., P. Spacciapoli, L. T. Tran, T. Xu, F. D. Roberts, M. Dalla Serra, D. K. Buxton, F. G. Oppenheim, and P. Friden. 2001. Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob. Agents Chemother. 45:1367-1373. [PMC free article] [PubMed]
28. Ruissen, A. L., J. Groenink, E. J. Helmerhorst, E. Walgreen-Weterings, W. Van't Hof, E. C. Veerman, and A. V. Nieuw Amerongen. 2001. Effects of histatin 5 and derived peptides on Candida albicans. Biochem. J. 356:361-368. [PubMed]
29. Schagger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379. [PubMed]
30. Silverman, S., Jr., L. Luangjarmekorn, and D. Greenspan. 1984. Occurrence of oral Candida in irradiated head and neck cancer patients. J. Oral Med. 39:194-196. [PubMed]
31. Tam, J. P., Y. A. Lu, and J. L. Yang. 2002. Correlations of cationic charges with salt sensitivity and microbial specificity of cystine-stabilized beta-strand antimicrobial peptides. J. Biol. Chem. 277:50450-50456. [PubMed]
32. Tsai, H., and L. A. Bobek. 1998. Human salivary histatins: promising anti-fungal therapeutic agents. Crit. Rev. Oral Biol. Med. 9:480-497. [PubMed]
33. Tsai, H., and L. A. Bobek. 1997. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species. Antimicrob. Agents Chemother. 41:2224-2228. [PMC free article] [PubMed]
34. Uemura, T., K. Kashiwagi, and K. Igarashi. 2007. Polyamine uptake by DUR3 and SAM3 in Saccharomyces cerevisiae. J. Biol. Chem. 282:7733-7741. [PubMed]
35. Uemura, T., K. Kashiwagi, and K. Igarashi. 2005. Uptake of putrescine and spermidine by Gap1p on the plasma membrane in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 328:1028-1033. [PubMed]
36. Vanden Bossche, H., D. W. Warnock, B. Dupont, D. Kerridge, S. Sen Gupta, L. Improvisi, P. Marichal, F. C. Odds, F. Provost, and O. Ronin. 1994. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mycol. 32:189-202.
37. Vylkova, S., N. Nayyar, W. Li, and M. Edgerton. 2007. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob. Agents Chemother. 51:154-161. [PMC free article] [PubMed]
38. Xu, T., S. M. Levitz, R. D. Diamond, and F. G. Oppenheim. 1991. Anticandidal activity of major human salivary histatins. Infect. Immun. 59:2549-2554. [PMC free article] [PubMed]
39. Xu, Y., I. Ambudkar, H. Yamagishi, W. Swaim, T. J. Walsh, and B. C. O'Connell. 1999. Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization. Antimicrob. Agents Chemother. 43:2256-2262. [PMC free article] [PubMed]
40. Zhu, J., P. W. Luther, Q. Leng, and A. J. Mixson. 2006. Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: role of endocytosis and treatment implications. Antimicrob. Agents Chemother. 50:2797-2805. [PMC free article] [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)